WallStreetZenWallStreetZen

NASDAQ: XENE
Xenon Pharmaceuticals Inc Stock Ownership - Who owns Xenon Pharmaceuticals?

Insider buying vs selling

Have Xenon Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Elizabeth A. GarofaloDirector2024-03-082,092$45.69
$95.58kSell
Elizabeth A. GarofaloDirector2024-03-081,408$46.16
$64.99kSell
Elizabeth A. GarofaloDirector2024-03-083,500$18.56
$64.96kBuy
Sherrington RobinEVP Strategy Innovation2024-03-071,234$9.85
$12.15kBuy
Steven GannonDirector2024-03-075,000$46.25
$231.25kSell
Steven GannonDirector2024-03-071,000$46.45
$46.45kSell
Sherrington RobinEVP Strategy Innovation2024-03-077,407$9.85
$72.96kBuy
Sherrington RobinEVP Strategy Innovation2024-03-07215$45.96
$9.88kSell
Steven GannonDirector2024-03-075,000$46.30
$231.52kSell
Steven GannonDirector2024-03-072,000$46.20
$92.40kSell

1 of 4

XENE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XENE insiders and whales buy or sell their stock.

XENE Shareholders

What type of owners hold Xenon Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC8.75%6,601,830$244.86MInstitution
Avoro Capital Advisors LLC7.51%5,666,666$210.18MInstitution
Driehaus Capital Management LLC5.73%4,321,740$160.29MInstitution
Wellington Management Group LLP5.20%3,922,058$145.47MInstitution
Capital World Investors3.55%2,681,537$99.46MInstitution
Polar Capital Holdings PLC3.46%2,612,108$96.88MInstitution
Paradigm Biocapital Advisors LP3.29%2,484,874$92.16MInstitution
Capital International Investors3.28%2,475,859$91.83MInstitution
Commodore Capital LP2.87%2,167,793$80.40MInstitution
Blackrock Inc2.81%2,121,928$78.70MInstitution

1 of 3

XENE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XENE96.73%3.27%Net Selling
DYN72.42%27.58%Net SellingNet Selling
IDYA91.35%8.65%Net SellingNet Buying
MOR29.73%0.00%
FOLD66.45%33.55%Net SellingNet Selling

Xenon Pharmaceuticals Stock Ownership FAQ

Who owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals (NASDAQ: XENE) is owned by 97.29% institutional shareholders, 3.29% Xenon Pharmaceuticals insiders, and 0.00% retail investors. Evan A. Stein is the largest individual Xenon Pharmaceuticals shareholder, owning 1.04M shares representing 1.38% of the company. Evan A. Stein's Xenon Pharmaceuticals shares are currently valued at $38.73M.

If you're new to stock investing, here's how to buy Xenon Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.